SCHEMBL7823218

SCHEMBL7823218

[CH2]c1cc(I)c2ccccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
HSD17B10 Q99714 5/20 0.41
HIF1A Q16665 2/20 0.41
CYP1B1 Q16678 2/20 0.41
GRIN2D O15399 1/20 0.38
GRIN2A Q12879 1/20 0.38
GRIN2C Q14957 1/20 0.38
TRPM4 Q8TD43 1/20 0.37
CYP2A6 P11509 2/20 0.36
TSHR P16473 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
CYP1A2 P05177 5/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
HTR2A P28223 1/20 0.35
NQO2 P16083 1/20 0.35
HPGD P15428 4/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
GLA P06280 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6834828 0.76 ALDH1A1 (0.44) ALDH1A1HSD17B10HIF1ACYP1B1TRPM4
SCHEMBL18459198 0.76 ALDH1A1 (0.44) ALDH1A1HSD17B10HIF1ACYP1B1GRIN2D
SCHEMBL7837370 0.76 PLAU (0.33) ALDH1A1HSD17B10HIF1ACYP1B1CYP1A2
SCHEMBL28770513 0.74 CYP1A2 (0.46) ALDH1A1HSD17B10HIF1ACYP1B1GRIN2D
SCHEMBL942452 0.73 GRIN2D (0.55) ALDH1A1HSD17B10HIF1ACYP1B1GRIN2D
SCHEMBL1161945 0.73 NQO2 (0.61) ALDH1A1HSD17B10HIF1ACYP1B1GRIN2D
SCHEMBL158141 0.73 NQO2 (0.61) ALDH1A1HSD17B10HIF1ACYP1B1TRPM4
SCHEMBL7834992 0.73 HPRT1 (0.47) ALDH1A1HSD17B10HIF1ACYP1B1TRPM4
SCHEMBL7835644 0.73 CYP2A6 (0.50) ALDH1A1HSD17B10HIF1ACYP1B1TRPM4
SCHEMBL7823220 0.73 CYP1A2 (0.61) ALDH1A1HSD17B10HIF1ACYP1B1GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
CN-1066729-C Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-06-06 CN disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
CN-1157288-A Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1997-08-20 CN disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
EP-0745600-A1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-12-04 EP disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed